Free Shipping on orders over £20 | Same Day Dispatch on orders placed before 16:00

Neuro and signalling

PE-22-28

5mg lyophilised powderCAS 1801959-12-5

A short peptide fragment from the sortilin propeptide that blocks the TREK-1 potassium channel, used in ion-channel electrophysiology.

£23.90per vial, VAT included

In stock, dispatched same day before 16:00

  • Free shipping on UK orders over £20.00
  • Same day dispatch on orders placed before 16:00
  • Batch certificate in the COA Database

Sold for research purposes only. For in-vitro laboratory research. Not a medicine and not for human or animal consumption. Supplied to qualified individuals aged 18 and over; you confirm this at checkout.

Research overview

PE-22-28 is a seven-residue peptide, Gly-Val-Ser-Trp-Gly-Leu-Arg (GVSWGLR), taken from the sortilin propeptide and listed as a spadin-derived peptide. It is described as blocking the TREK-1 potassium channel and is used in ion-channel electrophysiology, including patch-clamp work on transfected cells and cultured neurons. Supplied at 5mg as a lyophilised powder for in-vitro laboratory research only.

TREK-1 is a two-pore-domain potassium channel that helps set resting membrane potential and responds to stretch, temperature, lipids and pH. The sortilin propeptide fragment spadin was reported to block TREK-1, and PE-22-28 is a shorter derivative described as keeping that blocking activity while being easier to make. In rodent neuron and cell-line preparations, TREK-1 blockade is reported to alter neuronal firing, which has made the channel a topic in neuropharmacology research.

Typical work uses patch-clamp recordings in HEK293 or COS-7 cells expressing TREK-1, with the peptide applied to the bath, and in cultured cortical or raphe neurons. Selectivity checks against other potassium channels, such as TREK-2 and TRAAK, are standard. Binding and stability studies by HPLC also feature. It is supplied as a lyophilised powder in a 5mg vial.

Research areas

  • TREK-1 potassium channel blockade
  • Patch-clamp recordings in transfected cells
  • Firing properties of cultured cortical or raphe neurons
  • Selectivity against other two-pore-domain channels
  • Sortilin propeptide fragment pharmacology

Specifications

CAS number
1801959-12-5
Molecular formula
C35H55N11O9
Molecular weight
~773.89 g/mol
Sequence
Gly-Val-Ser-Trp-Gly-Leu-Arg
One-letter code
GVSWGLR
Form
lyophilised powder
Purity
≥99% (HPLC)
Also known as
PE-22-28, PE 22-28, spadin-derived peptide, sortilin propeptide (22-28) fragment
Supplied as
5mg per vial, lyophilised powder

Storage and handling

Store the lyophilised powder in a freezer, protected from moisture and light, and let the vial reach room temperature before opening. Reconstitute with an appropriate laboratory diluent and keep reconstituted material cold.

Certificates of analysis

Each lot of PE-22-28 is released with a certificate recording identity and purity. Enter the lot number printed on your vial on the lab testing page to view it.

Questions

How is PE-22-28 related to spadin?

Spadin is a longer peptide released from the sortilin propeptide. PE-22-28 is a seven-residue derivative, GVSWGLR, described as keeping the TREK-1 blocking activity in a shorter form.

How is PE-22-28 supplied and stored?

It is a lyophilised powder in a 5mg vial. Keep it cold, dry and away from light, and reconstitute with a suitable laboratory diluent or recording buffer only when the material is needed.

Is PE-22-28 a medicine?

No. It is supplied strictly for in-vitro laboratory research. It is not a medicine, food or supplement, and it is not for human or animal use. Buyers must be aged 18 or over.

PE-22-28 5mg
£23.90

Before you continue

labsptg.com supplies research chemicals to qualified individuals for laboratory research only. These products are not medicines and are not for human or animal consumption.

By clicking Enter site you confirm that you are over 18 and acting as a qualified person for legitimate research purposes.

Leave site